Baxter Reports First-Quarter 2024 Results : vimarsana.com

First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company’s previously issued...

Related Keywords

Taiwan , United States , Ukraine , Red Sea , Djibouti General , Djibouti , China , Joee Almeida , , European Union , Department Of Justice , European Medicines Agency , Biopharma Solutions , Drug Administration , Linkedin , Dose Iq Safety Software , Baxter Biopharma Solutions , Baxter International Inc , Connectivity Solutions , Foreign Exchange , Mission To Save , Facebook , Baxter International , Drug Compounding , Medical Products , Kidney Care , Healthcare Systems , Integrated Supply , Connectivity Suite , Dextrose Injection , Sodium Chloride Injection , Hydrochloride Injection , Investor Relations , Regulations K , Middle East , Attorney General , Accepted Accounting Principles , Months Ended March , Continuing Operations Before Income , Chronic Therapies , Acute Therapies , Segment Net , Segment Sales , Cash Flow , Free Cash , Total Baxter , Net Sales Growth As Reported , Constant Currency Sales , Three Months Ended March , Second Quarter , Full Year , Projected Constant Currency Sales Growth , Projected Second Quarter , Earnings Per , Markets ,